FTSE All-Share
5.543,09
PKT
+1,85
PKT
+0,03
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.04.20 | Rio Tinto buy | Goldman Sachs Group Inc. | |
| 03.04.20 | Prudential Sector Perform | RBC Capital Markets | |
| 03.04.20 | National Grid Hold | Deutsche Bank AG | |
| 03.04.20 | Shell (ex Royal Dutch Shell) Neutral | JP Morgan Chase & Co. | |
| 03.04.20 | Shell (ex Royal Dutch Shell) Neutral | JP Morgan Chase & Co. | |
| 03.04.20 | BP overweight | JP Morgan Chase & Co. | |
| 03.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 03.04.20 | Diageo Underweight | JP Morgan Chase & Co. | |
| 02.04.20 | Prudential Sector Perform | RBC Capital Markets | |
| 02.04.20 | BP buy | UBS AG | |
| 02.04.20 | National Grid Outperform | RBC Capital Markets | |
| 02.04.20 | Prudential overweight | Barclays Capital | |
| 02.04.20 | Vodafone Group Outperform | Credit Suisse Group | |
| 02.04.20 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 02.04.20 | BP Neutral | Credit Suisse Group | |
| 02.04.20 | Unilever buy | Goldman Sachs Group Inc. | |
| 02.04.20 | Unilever buy | Goldman Sachs Group Inc. | |
| 02.04.20 | BAT buy | UBS AG | |
| 02.04.20 | Prudential Neutral | JP Morgan Chase & Co. | |
| 02.04.20 | Barclays overweight | JP Morgan Chase & Co. | |
| 02.04.20 | HSBC Underweight | JP Morgan Chase & Co. | |
| 02.04.20 | Lloyds Banking Group Neutral | JP Morgan Chase & Co. | |
| 01.04.20 | BP Underperform | RBC Capital Markets | |
| 01.04.20 | HSBC Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.04.20 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 01.04.20 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 01.04.20 | Lloyds Banking Group Outperform | RBC Capital Markets | |
| 01.04.20 | HSBC Underperform | RBC Capital Markets | |
| 01.04.20 | Barclays Sector Perform | RBC Capital Markets | |
| 31.03.20 | Rio Tinto Equal-Weight | Morgan Stanley | |
| 31.03.20 | Shell (ex Royal Dutch Shell) Equal weight | Barclays Capital | |
| 31.03.20 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 31.03.20 | AstraZeneca buy | Deutsche Bank AG | |
| 31.03.20 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 31.03.20 | AstraZeneca buy | Oddo BHF | |
| 31.03.20 | GSK Neutral | Oddo BHF | |
| 31.03.20 | London Stock Exchange (LSE) Outperform | Credit Suisse Group | |
| 31.03.20 | HSBC Conviction Buy List | Goldman Sachs Group Inc. | |
| 31.03.20 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 31.03.20 | Barclays Neutral | Goldman Sachs Group Inc. |